# GB06 Phase III Trial for Pediatric Growth Hormone Deficiency

> **NCT07553351** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Kexing Biopharm Co., Ltd.** · enrollment: 192 (estimated)

## Conditions studied

- Growth Hormone Deficiency (GHD)
- Growth Hormone Deficiency in Children
- Growth Hormone Deficiency, Pediatric

## Interventions

- **DRUG:** GB06
- **DRUG:** Norditropin®FlexProTM

## Key facts

- **NCT ID:** NCT07553351
- **Lead sponsor:** Kexing Biopharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-07-25
- **Final completion:** 2028-10-24
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553351, "GB06 Phase III Trial for Pediatric Growth Hormone Deficiency". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07553351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*